Evaluating the optimal dose of teicoplanin with therapeutic drug monitoring: not too high for adverse event, not too low for treatment efficacy
Author:
Funder
Ministry of Trade, Industry and Energy
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s10096-019-03652-6.pdf
Reference27 articles.
1. Tobin CM, Lovering AM, Sweeney E, MacGowan AP (2010) Analyses of teicoplanin concentrations from 1994 to 2006 from a UK assay service. J Antimicrob Chemother 65(10):2155–2157. https://doi.org/10.1093/jac/dkq266
2. Outman WR, Nightingale CH, Sweeney KR, Quintiliani R (1990) Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses. Antimicrob Agents Chemother 34(11):2114–2117. https://doi.org/10.1128/aac.34.11.2114
3. Smithers JA, Kulmala HK, Thompson GA, Antony KK, Lewis EW, Ruberg SJ, Kenny MT, Dulworth JK, Brackman MA (1992) Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers. Antimicrob Agents Chemother 36(1):115–120. https://doi.org/10.1128/aac.36.1.115
4. Ulldemolins M, Roberts JA, Rello J, Paterson DL, Lipman J (2011) The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet 50(2):99–110. https://doi.org/10.2165/11539220-000000000-00000
5. Nah SY, Im JH, Yeo JY, Baek JH, Kim CW, Nam MS, Lee HK, Chung MH, Lee JS (2014) Therapeutic drug concentrations of teicoplanin in clinical settings. Infection & chemotherapy 46(1):35–41. https://doi.org/10.3947/ic.2014.46.1.35
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of pharmacist-driven antimicrobial stewardship interventions in a secondary care facility in Japan: A pragmatic quasi-experimental study;Journal of Infection and Chemotherapy;2024-08
2. Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Febrile Neutropenic Patients with Hematological Malignancies;Advances in Therapy;2024-05-14
3. Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Patients with Hematological Malignancies;2024-03-15
4. Thirty-Day Mortality of Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Insights from a Retrospective Cohort Study;Yonsei Medical Journal;2024
5. Population pharmacokinetics and model-based dosing optimization of teicoplanin in elderly critically ill patients with pneumonia;Journal of Critical Care;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3